Literature DB >> 19730880

Influence of donor- and recipient-specific factors on the postoperative course after combined pancreas-kidney transplantation.

Peter Thomas Fellmer1, Andreas Pascher, Andreas Kahl, Frank Ulrich, Katharina Lanzenberger, Konstanze Schnell, Sven Jonas, Stefan G Tullius, Peter Neuhaus, Johann Pratschke.   

Abstract

INTRODUCTION: Simultaneous pancreas-kidney (SPK) transplantation is state-of-the-art therapy for patients with type-1 diabetes mellitus and end-stage renal failure. Improvement of long-term organ function and long-term survival after transplantation is the main focus of current research, but improvement of the early postoperative course is very important for the patient. Pancreas transplantation is associated with postoperative complications. We defined and identified donor- and recipient-specific factors related to postoperative complications. PATIENTS AND METHODS: We carried out 210 SPKs from April 1995 to December 2007. The early postoperative course until first discharge from hospital was analyzed. Complications (pancreas-specific and surgical) were revisited. Donor-specific factors such as sex, age, body mass index (BMI), laboratory values, catecholamine administration, time in the intensive care unit, preprocurement blood substitution, and asystolic periods, as well as factors related to the organ donation procedure, were assessed. Recipient-specific factors such as age, sex, BMI, and blood group were correlated with the prevalence of complications and postoperative outcome. Donor-specific risk factors correlating with postoperative complications included donor age, BMI, and blood transfusion in the donor before organ donation.
RESULTS: Graft preservation with histidine-tryptophan-ketoglutarate perfusion solution was related to a significantly higher number of surgical complications.When analyzing recipient-specific factors, pre-existing cardiac diseases influenced the prevalence of postoperative complications. The duration of the transplantation procedure was associated with significantly more complications. The anastomosis time was not significantly related to an increased prevalence of complications. The choice of immunosuppression had a significant effect on pancreas-specific complications, demonstrating that antithymocyte globulin instead of daclizumab had a negative effect. Initial immunosuppression with tacrolimus combined with mycophenolate mofetil (MMF) caused significantly fewer pancreas-related complications in comparison with tacrolimus combined with rapamycin as well as compared with cyclosporine combined with MMF. A high level of C-reactive protein within the first 7 days after transplantation was significantly related to an increased prevalence of complications.
CONCLUSIONS: Early postoperative complications after combined pancreas-kidney transplantation have a considerable effect on short- and long-term outcomes. Several statistically relevant factors related to pancreas- or surgery-associated complications could be identified. These data may help to improve early outcome after SPK by consideration of relevant risk factors when choosing an organ and a recipient for transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 19730880     DOI: 10.1007/s00423-009-0552-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  29 in total

1.  Influence of pancreas and kidney transplant function on recipient survival.

Authors:  J Szmidt; T Grochowiecki; Z Gałazka; S Nazarewski; K Madej; S Frunze; W Chudziński; M Durlik; L Paczek; T Jakimowicz; W Rongies; A Kański
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

2.  How to recognize a suitable pancreas donor: a Eurotransplant study of preprocurement factors.

Authors:  M T Vinkers; A O Rahmel; M C Slot; J M Smits; W D Schareck
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

3.  Simultaneous pancreas-kidney transplantation in a large multicenter study: surgical complications.

Authors:  J Malaise; W Steurer; A Koenigsrainer; W Mark; R Margreiter; D Van Ophem; M Mourad; J P Squifflet
Journal:  Transplant Proc       Date:  2005 Jul-Aug       Impact factor: 1.066

4.  Surgical complications are the main cause of pancreatic allograft loss in pancreas-kidney transplant recipients.

Authors:  C V Sansalone; G Maione; P Aseni; I Mangoni; A De Roberto; S Soldano; E Minetti; M L Broggi; G Civati
Journal:  Transplant Proc       Date:  2005 Jul-Aug       Impact factor: 1.066

5.  Pancreas transplantation: advantages of both enteric and bladder drainage combined in a two-step approach.

Authors:  Pieter van de Linde; Paul J M van der Boog; Andrzej G Baranski; Johan W de Fijter; Jan Ringers; Alexander F M Schaapherder
Journal:  Clin Transplant       Date:  2006 Mar-Apr       Impact factor: 2.863

6.  Pancreas transplantation with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: is there a difference?

Authors:  Thomas Becker; Bastian Ringe; Miguel Nyibata; Andreas Meyer zu Vilsendorf; Harald Schrem; Rainer Lück; Michael Neipp; Jürgen Klempnauer; Hueseyin Bektas
Journal:  JOP       Date:  2007-05-09

Review 7.  Progress in pancreas transplantation and combined pancreas-kidney transplantation.

Authors:  Chang-Sheng Ming; Zhong-Hua Klaus Chen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-02

8.  Complication rate of pancreas retransplantation after simultaneous pancreas-kidney transplantation compared with pancreas after kidney transplantation.

Authors:  P Fellmer; K Lanzenberger; F Ulrich; A Pascher; J Langrehr; S Jonas; A Kahl; U Frei; P Neuhaus; J Pratschke
Journal:  Transplant Proc       Date:  2007-03       Impact factor: 1.066

9.  Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Lorenzo G Gallon; Johan Winoto; Darshika Chhabra; Michele A Parker; Joseph R Leventhal; Dixon B Kaufman
Journal:  Transplantation       Date:  2007-05-27       Impact factor: 4.939

10.  Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants.

Authors:  R W Gruessner; D L Dunn; A C Gruessner; A J Matas; J S Najarian; D E Sutherland
Journal:  Transplantation       Date:  1994-06-15       Impact factor: 4.939

View more
  4 in total

1.  Use of Ex Vivo Normothermic Perfusion for Quality Assessment of Discarded Human Donor Pancreases.

Authors:  A D Barlow; M O Hamed; D H Mallon; R J Brais; F M Gribble; M A Scott; W J Howat; J A Bradley; E M Bolton; G J Pettigrew; S A Hosgood; M L Nicholson; K Saeb-Parsy
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

2.  A composite risk model for predicting technical failure in pancreas transplantation.

Authors:  E B Finger; D M Radosevich; T B Dunn; S Chinnakotla; D E R Sutherland; A J Matas; T L Pruett; R Kandaswamy
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

3.  Clinical Impact of Preoperative Sarcopenia on the Postoperative Outcomes After Pancreas Transplantation.

Authors:  Yasunari Fukuda; Tadafumi Asaoka; Hidetoshi Eguchi; Kazuki Sasaki; Yoshifumi Iwagami; Daisaku Yamada; Takehiro Noda; Koichi Kawamoto; Kunihito Gotoh; Shogo Kobayashi; Toshinori Ito; Yutaka Takeda; Masahiro Tanemura; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

4.  Donor cardiac arrest and cardiopulmonary resuscitation: impact on outcomes after simultaneous pancreas-kidney transplantation - a retrospective study.

Authors:  Franka Messner; Yifan Yu; Joanna W Etra; Felix J Krendl; Valeria Berchtold; Claudia Bösmüller; Gerald Brandacher; Rupert Oberhuber; Stefan Scheidl; Manuel Maglione; Dietmar Öfner; Stefan Schneeberger; Christian Margreiter
Journal:  Transpl Int       Date:  2020-02-27       Impact factor: 3.782

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.